Skip to main content
logo
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.11
+0.34 (1.04%)
At close: Aug 1, 2025, 4:00 PM
32.99
-0.12 (-0.36%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Immunotherapies
310.20M
Log In
Log In
Log In
Log In
Upgrade
Immunotherapies Growth
24.37%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
United States
226.90M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
25.72%
Log In
Log In
Log In
Log In
Upgrade
Europe
73.22M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
8.27%
Log In
Log In
Log In
Log In
Upgrade
International
10.08M
Log In
Log In
Log In
Log In
Upgrade
International Growth
665.81%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
-
Log In
Log In
Log In
Log In
Upgrade